MARKET TALK: Avandia Panel Ripples Through Blogosphere

13th Jul 2010 16:26

11:26 (Dow Jones) Today's FDA advisory committee meeting to evaluate safety of GlaxoSmithKline's (GSK) diabetes drug Avandia is generating lots of buzz on Twitter and various health blogs. For a sample, try CardioBrief.org by longtime medical journalist Larry Husten, who's posting updates with a touch of irreverence every few minutes. ([email protected]) (http://cardiobrief.org/2010/07/13/day-1-of-the-fda-avandia-panel-live-blogging/) Call us at (212) 416-2181 or email [email protected] Visit the Market Talk blog at www.djnmarkettalk.com. (END) Dow Jones Newswires July 13, 2010 11:26 ET (15:26 GMT)